Brooklyn Immunotherapeuti Earnings Estimate

BTX
 Stock
  

USD 0.57  0.03  5.00%   

Many public companies, such as Brooklyn Immunotherapeuti, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Brooklyn Immunotherapeuti's earnings estimates, investors can diagnose different trends across Brooklyn Immunotherapeuti's analyst sentiment over time as well as compare current estimates against different timeframes.
Brooklyn Immunotherapeuti is projected to generate -2.79 in earnings per share on the 31st of December 2021. Brooklyn Immunotherapeuti earnings estimates module stress-tests analyst consensus about projected Brooklyn Immunotherapeutics EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Continue to Trending Equities.
  
Refresh
Gross Profit is likely to rise to about 12.2 M in 2022, whereas Profit Margin is likely to drop (0.13)  in 2022.

Brooklyn Immunotherapeuti Earnings Estimation Breakdown

Calculation of earning per share of Brooklyn Immunotherapeuti is based on official Zacks consensus of 0 analysts regarding Brooklyn Immunotherapeuti future annual earnings. Given the historical accuracy of 0.0%, the future earnings per share of Brooklyn Immunotherapeuti is estimated to be -2.79 with the lowest and highest values of -2.79 and -2.79, respectively. Please note that this consensus of annual earnings estimates for Brooklyn Immunotherapeutics is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -0.45
-2.79
Lowest
Expected EPS -2.79
-2.79
Highest

Brooklyn Immunotherapeuti Earnings Projection Consensus

Suppose the current estimates of Brooklyn Immunotherapeuti's value are higher than the current market price of the Brooklyn Immunotherapeuti stock. In this case, investors may conclude that Brooklyn Immunotherapeuti is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Brooklyn Immunotherapeuti's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

0

0.0%

-0.447

-2.79

Brooklyn Immunotherapeuti Earnings History

Earnings estimate consensus by Brooklyn Immunotherapeuti analysts from Wall Street is used by the market to judge Brooklyn Immunotherapeuti's stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Brooklyn Immunotherapeuti's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Brooklyn Immunotherapeuti Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

(8.33 Million)

Share
Accumulated Retained Earnings Deficit is likely to drop to about (172.3 M) in 2022. Earning Before Interest and Taxes EBIT is likely to drop to about (125.5 M) in 2022 Weighted Average Shares is likely to rise to about 46.7 M in 2022. Weighted Average Shares Diluted is likely to rise to about 46.7 M in 2022.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brooklyn Immunotherapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brooklyn Immunotherapeuti in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.506.36
Details
Intrinsic
Valuation
LowReal ValueHigh
0.204.059.91
Details
Naive
Forecast
LowNext ValueHigh
0.0116390.586.44
Details
2 Analysts
Consensus
LowTarget PriceHigh
9.0014.5020.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brooklyn Immunotherapeuti. Your research has to be compared to or analyzed against Brooklyn Immunotherapeuti's peers to derive any actionable benefits. When done correctly, Brooklyn Immunotherapeuti's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brooklyn Immunotherapeuti.
Note that many institutional investors and large investment bankers can move markets due to the volume of Brooklyn assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Brooklyn Immunotherapeuti. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Brooklyn stock price in the short term.

Brooklyn Immunotherapeuti Earnings per Share Projection vs Actual

Actual Earning per Share of Brooklyn Immunotherapeuti refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Brooklyn Immunotherapeutics predict the company's earnings will be in the future. The higher the earnings per share of Brooklyn Immunotherapeuti, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Brooklyn Immunotherapeuti Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Brooklyn Immunotherapeuti, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Brooklyn Immunotherapeuti should always be considered in relation to other companies to make a more educated investment decision.

Brooklyn Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Brooklyn Immunotherapeuti's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-04-15
2022-03-31-0.12-0.16-0.0433 
2021-12-31
2021-12-31-0.12-0.16-0.0433 
2021-11-12
2021-09-30-0.08-1.7-1.622025 
2021-08-13
2021-06-30None-0.24None
2021-06-30
2021-03-31None-0.2378None
2021-03-31
2020-12-31None-0.6368None
2020-11-11
2020-09-30None-1.0089None
2020-08-07
2020-06-30None-1.3887None
2020-06-30
2020-03-31None-0.1156None
2020-03-31
2019-12-31None-0.0582None
2019-10-10
2019-09-30None-0.2443None
2019-08-09
2019-06-30-0.05-0.2-0.15300 
2019-05-10
2019-03-31-0.060.30.36600 
2019-03-20
2018-12-310.30.22-0.0826 
2018-11-07
2018-09-30-0.080.160.24300 
2018-08-02
2018-06-30-0.46-0.10.3678 
2018-05-09
2018-03-31-0.54-0.320.2240 
2018-03-06
2017-12-31-0.28-0.5-0.2278 
2017-11-07
2017-09-30-0.42-0.140.2866 
2017-08-02
2017-06-30-0.35-0.070.2880 
2017-05-03
2017-03-31-0.39-0.040.3589 
2017-03-06
2016-12-31-0.19-0.22-0.0315 
2016-11-08
2016-09-30-0.48-0.310.1735 
2016-08-03
2016-06-30-0.52-0.460.0611 
2016-05-06
2016-03-31-1-0.560.4444 
2016-03-11
2015-12-31-0.5-0.50
2015-11-05
2015-09-30-1-0.50.550 
2015-08-06
2015-06-30-1.5-1.50
2015-05-07
2015-03-31None-2.4631None
2015-03-26
2014-12-31None-1.8714None
2014-11-06
2014-09-30None-1.4401None
2014-08-13
2014-06-30None-1.5175None
2014-05-14
2014-03-31None-0.8302None
2014-03-27
2013-12-31None-0.4751None
2013-11-14
2013-09-30None-0.3286None
2013-08-15
2013-06-30None-0.1393None
2013-05-10
2013-03-31None-0.5207None
2013-03-29
2012-12-31None0.8817None
2012-11-08
2012-09-30None0.0757None
2012-08-13
2012-06-30None-0.8978None
2012-05-10
2012-03-31None-1.6197None
2012-03-29
2011-12-31None-1.7201None
2011-11-10
2011-09-30None-1.3857None
2011-08-04
2011-06-30None-1.6295None
2011-05-11
2011-03-31None-0.9259None
2011-03-24
2010-12-31None0.5301None
2010-11-11
2010-09-30None0.2038None
2010-08-13
2010-06-30None-0.7593None
2010-05-14
2010-03-31None-0.6494None
2009-11-13
2009-09-30None-1.2833None
2009-08-14
2009-06-30None-0.4882None
2009-05-15
2009-03-31None-0.4618None
2009-03-20
2008-12-31None-1.8339None
2008-11-07
2008-09-30None-1.5526None
2008-08-08
2008-06-30None-4.248None
2008-05-09
2008-03-31None-4.6641None
2008-03-14
2007-12-31None-3.4801None
2007-11-08
2007-09-30-0.5-1.5-1200 
2007-08-08
2007-06-30-1-0.50.550 
2007-05-09
2007-03-31-1-0.50.550 
2007-03-14
2006-12-31None-5.414None
2006-11-08
2006-09-30-0.17-0.10110.068940 
2006-08-08
2006-06-30None-1.5None
2006-05-09
2006-03-310.170.1247-0.045326 
2006-03-16
2005-12-310.50.2861-0.213942 
2005-11-08
2005-09-30-0.50.40570.9057181 
2005-08-08
2005-06-30-1-10
2005-05-10
2005-03-31-1-10
2005-03-16
2004-12-31-1-1.5-0.550 
2004-11-09
2004-09-30None-2.3303None
2004-07-29
2004-06-30None-2.0378None
2004-05-10
2004-03-31-1-10
2004-03-15
2003-12-31-1-10
2003-11-13
2003-09-30None-1.5254None
2003-08-06
2003-06-30None-1.8768None
2003-04-30
2003-03-31None-0.6249None
2002-11-01
2002-09-30None-1.7545None
2002-07-25
2002-06-30-2-1150 
2002-03-31
2002-03-31None-0.43None
2001-12-31
2001-12-31None-1.0661None
2001-09-30
2001-09-30None-1.9905None
2001-06-30
2001-06-30None-2.5887None
2001-03-31
2001-03-31None-4.3429None
2000-09-30
2000-09-30None-3.5283None
2000-06-30
2000-06-30None-7.468None
2000-03-31
2000-03-31None-0.6361None
1999-09-30
1999-09-30None1.7283None
1999-06-30
1999-06-30None-1.6779None
1999-03-31
1999-03-31None-2.9848None
1998-09-30
1998-09-30None-1.1989None
1998-07-01
1998-06-30-4-6.5-2.562 
1998-03-31
1998-03-31None-2.5809None

About Brooklyn Immunotherapeuti Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Brooklyn Immunotherapeuti earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Brooklyn Immunotherapeuti estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Brooklyn Immunotherapeuti fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit-159.7 M-172.3 M
Earning Before Interest and Taxes EBIT-122.3 M-125.5 M
Earnings per Basic Share(2.82) (3.04) 
Earnings per Diluted Share(2.82) (3.04) 
Price to Earnings Ratio(1.48) (1.59) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-121.8 M-125 M
Earnings before Tax-122.3 M-125.5 M
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York. Brooklyn Immunotherapeuti operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange. It employs 10 people.

Brooklyn Immunotherapeuti Investors Sentiment

The influence of Brooklyn Immunotherapeuti's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Brooklyn. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Brooklyn Immunotherapeuti Implied Volatility

    
  0.0  
Brooklyn Immunotherapeuti's implied volatility exposes the market's sentiment of Brooklyn Immunotherapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Brooklyn Immunotherapeuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Brooklyn Immunotherapeuti stock will not fluctuate a lot when Brooklyn Immunotherapeuti's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brooklyn Immunotherapeuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brooklyn Immunotherapeuti's short interest history, or implied volatility extrapolated from Brooklyn Immunotherapeuti options trading.

Current Sentiment - BTX

Brooklyn Immunotherapeuti Investor Sentiment

Greater number of Macroaxis users are currently bullish on Brooklyn Immunotherapeutics. What is your opinion about investing in Brooklyn Immunotherapeutics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Continue to Trending Equities. Note that the Brooklyn Immunotherapeuti information on this page should be used as a complementary analysis to other Brooklyn Immunotherapeuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Brooklyn Stock analysis

When running Brooklyn Immunotherapeuti price analysis, check to measure Brooklyn Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn Immunotherapeuti is operating at the current time. Most of Brooklyn Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn Immunotherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn Immunotherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Is Brooklyn Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brooklyn Immunotherapeuti. If investors know Brooklyn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brooklyn Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
33 M
Return On Assets
-0.74
Return On Equity
-156.16
The market value of Brooklyn Immunotherapeuti is measured differently than its book value, which is the value of Brooklyn that is recorded on the company's balance sheet. Investors also form their own opinion of Brooklyn Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Brooklyn Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brooklyn Immunotherapeuti's market value can be influenced by many factors that don't directly affect Brooklyn Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brooklyn Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Brooklyn Immunotherapeuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brooklyn Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.